Featured Research

from universities, journals, and other organizations

Scrap 'unwinnable' drugs war and divert funds into curbing global antibiotic misuse, experts say

Date:
February 20, 2013
Source:
BMJ-British Medical Journal
Summary:
Governments around the world should stop squandering resources fighting an "unwinnable war" against illegal drugs, such as cocaine and heroin. Instead, they should use the cash to curb antibiotic misuse, which poses a far more serious threat to human health, claims a leading ethicist.

Governments around the world should stop squandering resources fighting an "unwinnable war" against illegal drugs, such as cocaine and heroin. Instead, they should use the cash to curb antibiotic misuse, which poses a far more serious threat to human health, claims a leading ethicist in the Journal of Medical Ethics.

Dr Jonny Anomaly, of Duke University, Durham in North Carolina, USA, says that concerted collective action is needed to tackle the excessive and casual prescribing of antibiotics, which has led to a worrying rise in resistance to these medicines.

"Government action is both more appropriate and more likely to be effective in regulating antibiotics than it is in criminalising narcotics," he writes.

Dr Anomaly says the arguments put forward for continuing to plough resources into the war on illegal drugs, such as the need to curb the related violence and social harms, should, of course, be taken seriously.

But he contends that "most of the violence and crime associated with narcotics is caused by laws that prohibit drug use, rather than drug use itself." And the argument that stimulant drugs increase violent tendencies is not based on strong evidence, he says.

He accepts that a drug habit takes its toll on friends and family, but argues that this does not justify treating this behaviour as a crime.

And while supporters of tough action on illegal drugs fear that the absence of harsh penalties will simply make it easier to get hold of them, Dr Anomaly points to the evidence in Portugal -- the only country that has decriminalised recreational drug use.

This "suggests that consumption has not significantly increased for most drugs, and has actually declined for some…greater accessibility does not necessarily lead to more drug use by either adults or children," he writes.

At the very least antibiotic resistant infections have the power to harm others and make illness more costly to treat, and they can often kill, he warns.

"This feature gives antimicrobial drugs a fundamentally different moral status from recreational drugs, and it suggests that current policy priorities are based on moral confusion, scientific ignorance, or both," he suggests.

He puts forward several possible ways of tackling antibiotic resistance.

These include phasing out the use of these drugs in farming, along with factory farming; cash incentives for pharmaceutical companies to conserve existing drugs; banning over the counter sales of antibiotics in developing nations; and global surveillance of resistant bacteria, spearheaded by the world's wealthy nations.

In addition to this, a flat user fee should be levied on courses of antibiotics, the monies from which could be used to fund antibiotic research, he suggests.

"A user fee would not be a panacea. But it could be a crucial part of a multidimensional approach to the problem of resistance. User fees are especially attractive because of their fairness and simplicity," he says.

[Collective action and individual choice: rethinking how we regulate narcotics and antibiotics Online First doi: 10.1136/medethics-2012-101160]


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Anomaly. Collective action and individual choice: rethinking how we regulate narcotics and antibiotics. Journal of Medical Ethics, 2013; DOI: 10.1136/medethics-2012-101160

Cite This Page:

BMJ-British Medical Journal. "Scrap 'unwinnable' drugs war and divert funds into curbing global antibiotic misuse, experts say." ScienceDaily. ScienceDaily, 20 February 2013. <www.sciencedaily.com/releases/2013/02/130220184955.htm>.
BMJ-British Medical Journal. (2013, February 20). Scrap 'unwinnable' drugs war and divert funds into curbing global antibiotic misuse, experts say. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/02/130220184955.htm
BMJ-British Medical Journal. "Scrap 'unwinnable' drugs war and divert funds into curbing global antibiotic misuse, experts say." ScienceDaily. www.sciencedaily.com/releases/2013/02/130220184955.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins